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Purpose: Transforming growth factor-β 2 is known to be present at elevated levels in the aqueous humor of 
patients with primary open angle glaucoma (POAG) and diabetes but not in uveitis-related secondary 
glaucoma. We investigated total TGF-β 2 levels and levels of the active form of TGF-β 2 in the aqueous humor 
of eyes with different types of glaucoma.
Methods: The concentration of the total and active form of TGF-β 2 was measured in 63 patients with primary 
open angle glaucoma, neovascular glaucoma complicated with diabetes (NVG), and secondary open angle 
glaucoma complicated with uveitis (SOAG) using a double antibody ‘sandwich-indirect’ ELISA method.
Results: The levels of total TGF-β 2 in the aqueous samples of POAG, NVG, and SOAG were elevated. The 
levels of active TGF-β 2 in the aqueous samples of POAG, and NVG were also elevated, whereas the level 
of active TGF-β 2 was within the normal range in the aqueous samples of SOAG.
Conclusions: These results suggest that the level of TGF-β 2 may play a role in the pathology of various 
types of glaucoma.  Korean Journal of Ophthalmology 20(3):162-165, 2006
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Transforming growth factor-β s (TGF-β s) constitute a 
family of multifunctional polypeptides of approximately 25 
kDa, and exhibit pleiotropic regulatory actions upon most 
vertebral cell types.
1,2 Depending on the cell type, they 
regulate proliferation, migration, differentiation, cytokine 
production, synthesis of extracellular matrix (ECM), wound 
healing, immunosuppression, and in vivo angiogenesis.
3 TGF-
β  exists in at least five genetically distinct isoforms, β 1-β 5.
4 
Among these, only three isoforms, namely β 1, β 2, and β 3, are 
expressed in human ocular tissues.
4 
TGF-β 2 is regarded as the major isoforms in the eye.
2-4 
Elevated levels of TGF-β 2 have been detected in the aqueous 
humor of glaucomatous eyes,
4-7 and reduced levels of active 
TGF-β 2 have been detected in the aqueous humor of uveitic 
eyes.
8 
In this study, we evaluated levels of total TGF-β 2 and the 
active form of TGF-β 2 in the aqueous humor of patients with 
different types of glaucoma (POAG, NVG, and SOAG), 




Aqueous humor was collected in the operating room from 
63 eyes of 63 human subjects (age range, 19 to 83 years; 
mean±standard deviation, 49.88±17.58) undergoing cataract 
or glaucoma surgery.
Patients were classified into four groups: those with POAG 
(group P; 14 patients), those with NVG complicated with 
diabetes (group N; 14 patients), those with SOAG compli-
cated with uveitis (group S; 15 patients), and those with only 
cataract (group C, control group; 20 patients).
In group P, the average preoperative intraocular pressure 
(IOP) was 21.8±5.7 mmHg. The patients had established 
diagnosis of advanced POAG that correlated with advanced 
visual field loss. The POAG patients received 2.51±0.76 
anti-glaucoma medications, and none of the patients had 
previous ocular surgery of any kind. In group N, the average SH  Min,  et  al.  TGF-β   Levels  in  Human  Aqueous  Humor
163
Fig. 1. C o n c e n t r a t i o n  o f  t o t a l  t r a n s f o r m i n g  g r o w t h  f a c t o r  ( T G F ) -
β 2 i n  t h e  a q u e o u s  h u m o r  o f  d i f f e r e n t  t y p e s  o f  g l a u c o m a .  
Fig. 2. C on ce ntra tio n of a c tiv e tra nsfo rm ing gro w th fac to r (T G F )-
β 2 i n  t h e  a q u e o u s  h u m o r  o f  d i f f e r e n t  t y p e s  o f  g l a u c o m a .  
preoperative IOP was 33.7±6.2 mmHg. All patients had 
proliferative diabetic retinopathy with rubeosis iridis. The 
patients were treated with 2.23±1.18 anti-glaucoma medi-
cations and panretinal photocoagulation (PRP). The anterior 
segment neovascularization was reduced in nine patients, but 
peripheral anterior synecia formation progressed. Five 
patients had peripheral anterior synecial closure at the time 
of PRP. In group S, the average preoperative IOP was 27.3±
4.7 mmHg. The patients had uveitis with anterior, inter-
mediate, posterior, and panuveitis of different origins. In 
group C, patients underwent elective cataract extraction with 
intraocular lens implantation. All patients had a normal ocular 
examination. Patients were excluded if they were taking 
topical medication or had an ocular condition that was being 
treated with topical or systemic medications. 
2. Interventions Preceding Aqueous Humor 
Sampling
All surgery was performed under local anesthesia, consist 
of 2% lidocaine hydrochloride, administered by retrobulbar 
and nadbath injection.
3. Collection of Aqueous Humor
All samplings were performed by the same surgeon. At the 
time of cataract or glaucoma surgery, a limbal paracentesis 
was made with a 20 G MVR knife (BD Ophthalmic systems, 
Bidford on Avon, Warks, B50 4JH, UK). Aqueous humor 
(100~200  μ L) was aspirated into a tuberculin microsyringe 
prior to any incisional surgical procedures. All samples were 
rapidly frozen and stored in a -70℃ freezer until analysis.
4. Detection and quantification of TGF-β 2 by ELISA
The concentration of TGF-β 2 in aqueous humor samples 
was quantified by a double antibody ‘sandwich-indirect’ 
enzyme-linked immunosorbent assay (R&D Systems, Min-
neapolis, MN, U.S.A.), with a sensitivity of 2 pg/ml. Intra- 
and inter-assay coefficients of variation for ELISA were 
within 7%. The concentration of TGF-β 2 in the aqueous 
humor samples was determined by comparison with a 
standard curve of activity of standard TGF-β 2. 
Briefly, 100 μ L standard TGF-β 2 or aqueous humor sample 
was added to a 96-well ELISA plates coated with murine 
monoclonal anti-TGF-β 2-antibodies. After 2 hours of incu-
bation at room temperature, the wells were washed three 
times with 400 μ L wash buffer. Each well was coated with 
200  μ L of polyclonal anti-TGF-β 2 antibodies conjugated to 
horseradish peroxidase. The mixture was incubated and 
washed, as previously described. 200 μ L substrate solution 
was added to each well, and the plate was incubated for 20 
minutes at room temperature to allow the reaction to proceed. 
50 μ L stop solution was then added to each well. Absorbance 
at 450 nm was measured with an immunoreader system 
(BIO-TEK, Winooski, VT, USA).
5. Acid Activation of the Aqueous Humor Samples
For the determination of total TGF-β 2, all of the aqueous 
humor samples were treated with 10 μ L 1N HCl, and left for 
10 minutes at room temperature to allow activation. Then, 10 
μ L 1.2 N NaOH/0.5 M HEPES was added for neutralization, 
and diluted with 340 μ L Calibrator Diluent. Determination of 
total TGF-β 2 was performed immediately.
6. Statistical Analysis
Statistical analysis was performed, using the Kruskall-Wallis Korean  J  Ophthalmol  Vol.20,  No.3,  2006
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test program. A multiple comparison was conducted, using 
the Mann-Whitney test. Significant differences were defined 
by P values below 0.05.
Results
The concentration of total and active TGF-β 2 in each 
group are shown in Fig. 1 and 2. The concentrations of total 
TGF-β 2 (mean±standard deviation) in the aqueous humor are 
shown in Fig. 1. The mean concentration of total TGF-β 2 in 
groups P, N, and S was 3824±890 pg/ml, 3264±221 pg/ml, 
and 1984±539 pg/ml, respectively. These values were 
significantly higher than that of group C (1392±177 pg/ml, 
p<0.05). 
The concentrations of active TGF-β 2 (mean±standard 
deviation) in the aqueous humor are shown in Fig. 2. The 
concentration of active TGF-β 2 in the aqueous humor of 
groups P, N, and S was 397±147 pg/ml, 535±126 pg/ml, 
and 277±136 pg/ml, respectively, compared with 233±66 
pg/ml for group C. Active TGF-β 2 levels in groups P and N 
were statistically significantly higher than that of the control 
group C (p<0.05). 
Discussion
The physiologic function of TGF-β 2 in the tissue of the 
eye is not yet fully understood. TGF-β 2 has previously been 
shown to increase accumulation of ECM components and 
stimulate neovascularization.
7,9-10 TGF-β 2 is thought to play 
an important role in the immunosuppressive function of 
aqueous humor for the maintenance of anterior chamber- 
associated immune deviation (ACAID).
11 
Tripathi et al.
10 reported that the mean concentrations of 
total and active TGF-β 2 in the aqueous humor of POAG were 
2700 pg/ml and 450 pg/ml, respectively, compared with 1480 
pg/ml and 200 pg/ml in the control group. Our study 
confirmed that the levels of both total and active TGF-β 2 
were significantly higher in group P than in group C. TGF-β 2 
plays a regulatory role in the accumulation of ECM by 
stimulating the synthesis and secretion of matrix proteins and 
protease inhibitors, and inhibits the synthesis of proteolytic 
enzymes.
12 It also inhibits proliferation and migration of 
trabecular cells in vitro.
13 Thus, high levels of total and active 
TGF-β 2 may contribute to the development of outflow resis-
tance in the pathogenesis of POAG.
Ochiai et al.
9 reported total TGF-β 2 levels of 1716 pg/ml, 
and 1001 pg/ml, respectively, in the aqueous of diabetics and 
control eyes. Another study reported that the concentrations 
of total and active TGF-β 2 in the vitreous of patients with 
proliferative diabetic retinopathy (PDR) were 2634 pg/ml and 
244 pg/ml, respectively.
14 The levels of total and active TGF-
β 2 in the vitreous of nondiabetic subjects were 1305 pg/ml 
and, 79 pg/ml, respectively.
14 We showed elevated levels of 
both total and active TGF-β 2 in NVG related to diabetes. An 
elevated concentration of TGF-β 2 in the aqueous humor of 
patients with NVG complicated with diabetes may result in 
neovascularization. Therefore, the production of TGF-β 2 in 
the eyes of NVG patients may have a different outcome from 
that in the eyes of POAG patients.
TGF-β 2 in aqueous humor contributes to the fluid’s 
immunosuppressive function and inhibits T-cell proliferation. 
Decreased levels of TGF-β 2 in the aqueous humor of uveitis 
have been reported in a previous study.
8 It has been reported 
that macroglobulin present in the serum binds TGF-β , 
inhibiting activation. The presence of such proteins in the 
aqueous humor of uveitic patients may lower the level of 
active TGF-β 2.
8 In this study, the level of active TGF-β 2 was 
not elevated when compared with the control; in fact, since 
the total level of TGF-β 2 in SOAG was higher than that of 
the control, the relative concentration of active TGF-β 2 is 
lower in the SOAG patients. Further studies will be required 
to improve our understanding of the roles of TGF-β 2 in the 
aqueous humor of various types of glaucomatous eyes. 
This study is the first report of increased levels of TGF-β 2 
in the aqueous humor of NVG complicated with diabetes in 
Korea. We demonstrate elevated concentrations of total TGF-
β 2 in the aqueous humor of patients with POAG, NVG, and 
SOAG. The concentrations of active TGF-β 2 in the aqueous 
humor are also elevated in POAG, and NVG, while the 
relative concentration of active TGF-β 2 in SOAG is decreased. 
TGF-β 2 may play a role in the pathology of various types 
of glaucoma. Further studies will be needed to elucidate the 
therapeutic implications for TGF-β 2 as an anti-inflammatory 
or immunosuppressant agent in the treatment of glaucoma. 
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